Skip to content
ABT Abbott Laboratories
$113.43 -0.36% -0.41
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ABT stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 198B
Enterprise value 205B
Trailing PE 34.607903
Forward PE 22.065893
PEG Ratio 22.065893
Enterprise to EBITDA 18.935
Enterprise to revenue 4.973
Price to book MRQ 4.9625173
Price to sales TTM 4.803131

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 41.2B
EBITDA 10.6B
Diluted EPS TTM 3.29
Total Cash (MRQ) 7.8B
Current ratio (MRQ) 1.597
Operating Cash Flow (TTM) 8.7B

ABT trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent ABT News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.